The impact of COVID-19 on the management of patients with non-small cell lung cancer (NSCLC) will take some time to unfold in full but early evidence suggests the infection warrants a change in the duration and type of cancer treatment. A Commentary article in Future Medicine by Australian authors said the pandemic poses significant challenges ...
Changes in therapy for lung cancer patients may be needed due to COVID-19
By Mardi Chapman
7 May 2020